Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases;Allogene beenmergtransplantatie bij de behandeling van (lysosomale) stapelingsziekten

Nederlands Tijdschrift voor Geneeskunde

Volumn 142, Issue 4, 1998, Pages 169-174

  Maaswinkel Mooij, P D ^a   Poorthuis, B J H M ^a   Hoogerbrugge, P M ^a   Brouwer, O F ^a   Vossen, J M J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; DISEASE COURSE; HUMAN; HURLER SYNDROME; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; SKELETON MALFORMATION; TREATMENT INDICATION;

ADRENOLEUKODYSTROPHY; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKODYSTROPHY, METACHROMATIC; LYSOSOMAL STORAGE DISEASES; MALE; MUCOPOLYSACCHARIDOSIS I; TREATMENT OUTCOME;

EID: 0032561969     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kayne EM. Therapeutic approaches to lysosomal storage diseases. Current Opinion in Pediatrics 1995;7:650-4.
2. Barton NW, Brady RO, Dambrosia JM. Di Besceglie AM, Doppelt SH, Hill SC, et al. Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med 1991;324:1464-70.
3. Hobbs JR, Hugh-Jones K, Barrelt AG, Byrom N, Chambers DCO. Henry K, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981;ii:709-12.
4. Hoogerbrugge PM, Brouwer OF, Bordigoni P, Ringdén O, Kapaun P, Ortega JJ, et al. Allogeneic bone marrow transplantation for lysosomal storage diseases. European Group for Bone Marrow Transplantation. Lancet 1995;345:1398-402.
5. Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG. The future for treatment by bone marrow transplantation for adrenoleukodystrophy. metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995;18:398-412.
6. Vassal G, Fischer A, Challine D, Boland I. Ledheist F, Lemerle S, et al. Busulfan disposition below the age of three: alteration in children with lysosomal storage disease. Blood 1993;82:1030-4.
7. Whitley CB, Belani KG, Chang PN, Summers CG, Blazar BR, Tsai MY, et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 1993;46:209-18.
8. Vellodi A, Young EP, Cooper A, Wraith JE, Winchester B. Meaney C, et al. Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 1997;76: 92-9.
9. Krivit W, Shapiro E, Kennedy W, Lipton M, Lockman L, Smith S, et al. Treatment of late infantile metachromatic leukodystrophy by bone marrow transplantation. N Engl J Med 1990;322:28-32.
10. Shapiro EG, Lockman LA, Balthazor M. Krivit W Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-29.
11. Moser HW. Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy. J Neuropathol Exp Neurol 1995; 54:740-5.
12. Aubourg P, Blanche S, Jambaqué I, Rocchiccioli F, Kalifa G, Naud-Saudreau C, et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation N Engi J Med 1990;322:1860-6.
13. Vossen JMJJ. Bone marrow transplantation in children. Ballieres Clin Paediatr 1994;1:1029-59.
14. Hickey WF, Vass K, Lassman NH. Bone marrow derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 1992; 51:246-56.
15. Vass K, Hickey WF, Schmidt RE, Lassmann H. Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chemeric rats. Lab Invest 1993;69:275-82.
16. Reuser AJJ. Cel en ziekte V. Pathologie van het lysosoom Ned Tijdschr Geneeskd 1993;137:2028-34.
17. Haskins M, Baker HJ, Birkenmeier E, Hoogerbrugge PM, Poorthuis BJHM, Sakiyama T, et al. Transplantation in animal model systems. In: Desnick RJ, editor. Treatment of genetic diseases. New York: Churchill Livingstone. 1991:183-201.
18. Poorthuis BJHM, Romme AE, Willemsen R, Wagemaker G. Bone marrow transplantation has a significant effect on enzyme levels and storage of glycosaminoglycans in tissues and in isolated hepatocytes of mucopolysaccharidosis type VII mice. Pediatr Res 1994;36:187-93.
19. Walkley SU, Thrall MA, Dobrenis K, Huang M, March PA, Siegel DA, et al. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proc Natl Acad Sci USA 1994;91:2970-4.
20. Whitley CB, Ramsay NKC, Kersey JH, Krivit W. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. In: Krivit W, Paul NW, editors. Bone marrow transplantation for treatment of lysosomal storage diseases. New York: Liss. 1986:7-24.
21. Feder N. Solitary cells and enzyme exchange in tetraparental mice. Nature 1976;263:67-9.
22. Neufeld EF. The uptake of enzymes into lysosomes: an overview. Birth Defects 1980;16.77-84.
23. Barranger JA Marrow transplantation in genetic disease N Engl J Med 1984;311:1629-31.
24. Hoogerbrugge PM, Suzuki K, Suzuki K. Poorthuis BJHM, Kobayashi T, Wagemaker G, et al. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation. Science 1988;239:1035-8.
25. Krivit W, Sung JH, Shapiro EG, Lockman LA. Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 1995;4:385-92.
26. Walkley SU, Dobrenis K. Bone marrow transplantation for lysosomal diseases. Lancet 1995;345:1382-3.
27. Walkley SU, Thrall MA, Dobrenis K, March P, Wurzelmann S. Bone marrow transplantation in neuronal storage diseases. Brain Pathol 1994;4:346.
28. McKinnis EJR, Sulzbacher S, Rutledge JC, Sanders J, Scott CR. Bone marrow transplantation in Hunter syndrome. J Pediatr 1996; 129:145-8.
29. Bergstrom SK, Quinn JJ, Greenstein R, Ascensao J. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review. Bone Marrow Transplant 1994;14: 653-8.
30. Klein KA, Krivit W, Whitley CB, Peters C, Cool VA, Fuhrman, et al. Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment. Bone Marrow Transplant 1994;15:176-81.
31. Vellodi A, Young E, New M, Pot-Mees C, Jones KH. Bone marrow transplantation for Sanfilippo diseases type B. J Inherit Metab Dis 1992,15:911-8.
32. Krivit W, Shapiro E. Bone marrow transplantation for storage diseases. In: Desnick RJ, editor. Treatment of genetic diseases. New York: Churchill Livingstone, 1991:203-21.
33. Krivit W. Maroteaux-Lamy syndrome: treatment by allogenic bone marrow transplantation in 6 patients and potential for autotransplantation bone marrow gene insertion. Int Pediatr 1992;7:47-52
34. Ringdén O, Groth CG, Erikson A, Granqvist S, Mansson JE, Sparrelid E. Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation 1995;59:864-70.
35. Hobbs JR, Jones KH, Shaw PJ, Lindsay I, Hancock M. Beneficial effect of pre-transplant splenectomy on displacement bone marrow transplantation for Gaucher's syndrome. Lancet 1987;i:1111-5